Diabetes complications

Glomerular Hyperfiltration Predicts Kidney Function Decline and Mortality in Type 1 and Type 2 Diabetes: A 21-Year Longitudinal Study

Diabetes CarePublished Retrospective cohort study

Authors' conclusion

Glomerular hyperfiltration, similar to hypofiltration, increases the combined risk of worsening kidney function and mortality from cardiovascular or renal causes in patients with diabetes. These findings encourage the active screening of these patients to optimize risk stratification and treatment of subclinical kidney disease.

Study context

Population
Patients with long-standing T1D or T2D
Participants
314 patients
Exposure
High or low measured GFR vs normal measured GFR
  • High mGFR (H-mGFR)n = 63
  • Low mGFR (L-mGFR)n = 63
  • Normal mGFR (N-mGFR)n = 188reference
Outcome
Composite of:
  • Doubling of serum creatinine
  • End-stage kidney disease (ESKD)
  • Cardiorenal death
Follow-up
Median 21.0 years
Methodological detailslongitudinal, 21-year follow-up
  • Longitudinal
  • 21-year follow-up

Main finding

As reported in the abstract

Primary composite outcome
Each group vs N-mGFRHazard ratio (95% CI)
H-mGFR
2.09(1.25–3.49)
L-mGFR
1.81(1.05–3.16)

Observational data: associations, not effects.

Further findings

OutcomeHR (CI)
Kidney-specific composite (doubling of serum creatinine, ESKD or renal death)H-mGFRvs N-mGFR4.95 (2.21–11.09)
Kidney-specific composite (doubling of serum creatinine, ESKD or renal death)L-mGFRvs N-mGFR3.81 (1.70–8.56)
Doubling of serum creatinineH-mGFRvs N-mGFR4.86 (2.18–10.90)
Doubling of serum creatinineL-mGFRvs N-mGFR4.04 (1.77–9.20)
Cardiorenal deathH-mGFRvs N-mGFR2.18 (1.24–3.83)
Cardiorenal deathL-mGFRvs N-mGFR2.26 (1.27–4.01)

Original publication

Glomerular Hyperfiltration Predicts Kidney Function Decline and Mortality in Type 1 and Type 2 Diabetes: A 21-Year Longitudinal Study. Diabetes Care. Published 14 February 2023. doi:10.2337/dc22-2003

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.